What are the Treatment Options for Acute Myeloid Leukemia?

Published: Apr 15, 2024

Treating Acute Myeloid Leukemia (AML) involves several strategies. Let's dive into the common therapies available.

Induction Therapy

Induction therapy is the first phase of AML treatment aimed at achieving remission. This often involves chemotherapy to kill as many leukemia cells as possible. The goal is to reduce the number of cancer cells to undetectable levels.

Consolidation Therapy

Once remission is achieved, consolidation therapy follows to eliminate any remaining leukemia cells. This phase uses higher doses of chemotherapy or potentially a stem cell transplant to prevent relapse.

Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow characterized by an overproduction of immature white blood cells.

Targeted Therapy

Targeted therapies use drugs that specifically attack cancer cell mutations. These therapies are chosen based on genetic testing results and can be more effective with fewer side effects than traditional chemotherapy.

Frequently Asked Questions

Induction therapy is the initial treatment phase to achieve remission.

It aims to destroy any remaining leukemia cells post-remission.

It targets specific cancer cell mutations for more precise treatment.

Key Takeaways

Choosing the right treatment path is vital for managing AML effectively.

Explore your treatment options by talking to Doctronic today.

Related Articles

References

Döhner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 2022; 140:1345.

Always discuss health information with your healthcare provider.